'Plug-and-play' CAR T technology adapts as cancer changes

Researchers from City of Hope have developed a new "plug-and-play" technology that adds engineered molecules to chimeric antigen receptor (CAR) T cells after treatment, allowing scientists to better control the cells and ...

page 1 from 40